The spike protein from the vaccine has special building blocks (proline) that make it harder for the body to break down, so it might stick around longer.
Evidence from Studies
Supporting (1)
Community contributions welcome
The study shows that the spike protein from vaccines sticks around in the body for months, and explains that parts of it, especially involving proline, are tough to break down—supporting the idea that proline helps it last longer.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Link proline-stabilized spike protein to longer half-life in vivo.
A cohort study of 100 vaccinated individuals with serial blood and tissue sampling to measure spike protein degradation rates using mass spectrometry, comparing cleavage patterns and half-life to wild-type spike protein in matched in vitro systems.
Compare detectability of proline-stabilized vs wild-type spike proteins in human samples.
A cross-sectional analysis of blood samples from 200 individuals post-vaccination and 100 post-infection, measuring full-length spike protein persistence using antibodies specific to cleavage-resistant epitopes.
Propose a plausible biochemical mechanism for observed persistence.
A narrative review integrating protein chemistry, vaccine design, and clinical observations to explain spike stability, such as the current article.